Annual cervical cancer screening or follow-up in high-risk women
This measure identifies women age 12 to 65 diagnosed with cervical dysplasia (CIN 2), cervical carcinoma-in-situ, or HIV/AIDS prior to the measurement year, and who still have a cervix, who had a cervical CA screen during the measurement year.
Date Reviewed: November 7, 2015
Support
Group/Practice
Individual Clinician
Integrated Delivery System
Population: Community, County, or City, Regional and State
Measure Info
NQF 0579NQF Endorsement RemovedCQMC Core Measure
Measure Type:
Process
Measure Steward:
Resolution Health Inc.
Clinical Topic Area:
Cancer Screening
HIV
Women's Preventive Services
Care Setting:
Ambulatory Care
Data Source:
Claims
Electronic Health Data
ACP supports this measure because it aligns with the American College of Obstetrics and Gynecology guideline. The measures is also indirectly supported by United States Preventive Services Task Force (USPSTF) guideline on cervical cancer screening, which states that women who are immunocompromised should not be held to the same screening standards as the general population.